Space-Based AI

Business

FDA Greenlights Intellia's Key Gene Therapy Trial, Paving Way for Potential Breakthrough

The U.S. Food and Drug Administration has removed a clinical hold on Intellia Therapeutics' pivotal Phase 3 study of its gene-editing candidate for a rare, progressive disease, allowing the trial to proceed with enhanced safety monitoring. The move refocuses investor attention on the company's pipeline and long-term valuation prospects.

Feb 3, 2026

Business

Beyond the FTSE Gloom: Three Sub-£400M UK Stocks Catching Investors' Eyes

Amid broader market pressures, a closer look at the UK's small-cap segment reveals potential opportunities. We examine three companies—CyanConnode, TPXimpact, and Gulf Keystone Petroleum—navigating challenges while showing flashes of promise for risk-tolerant investors.

Feb 3, 2026

Business

Vitalik Buterin Diverts $1.6M in Ethereum to Fund Philanthropic and Tech Initiatives

Ethereum co-founder Vitalik Buterin has executed planned sales of over 700 ETH, channeling approximately $1.63 million to his charitable organization Kanro and long-term development projects, with minimal market impact.

Feb 3, 2026

Business

Stoneridge Divests Control Devices Unit in $59M Deal, Sharpens Focus on High-Tech Vehicle Solutions

Stoneridge, Inc. has completed the sale of its Control Devices segment to private equity firm Center Rock Capital Partners for $59 million. The move is part of a strategic pivot to strengthen its balance sheet and concentrate resources on advanced vision, safety, and connectivity technologies for commercial vehicles.

Feb 3, 2026

Business

Insider Confidence: UK Growth Stocks Where Management Has Skin in the Game

Amid global economic crosscurrents, UK investors are turning their focus to growth companies with significant insider ownership, a signal often interpreted as strong alignment between leadership and shareholder interests. We examine three such firms standing out in the current market.

Feb 3, 2026

Business

Wedbush Bullish on Amazon Ahead of Q4 Earnings, Eyes $340 Target on AWS Momentum

Analyst Dan Ives of Wedbush reiterates an Outperform rating on Amazon, citing robust cloud growth and a positive setup for the upcoming quarterly report. The firm forecasts strong operating income and sees 2026 as a potential inflection year for AWS.

Feb 3, 2026

Business

Arcellx Stock: A Tale of Two Valuations Amid Biotech Volatility

Arcellx (ACLX) shares are caught in a tug-of-war between conflicting valuation signals. While a sky-high price-to-book ratio suggests the stock is richly valued, a discounted cash flow model implies massive upside potential. We examine the data behind the biotech's recent price swings and what investors are really betting on.

Feb 3, 2026

Business

Gilead's Oncology Ambitions Advance as Trodelvy-Keytruda Combo Shows Promise in Aggressive Breast Cancer

Gilead Sciences reports compelling Phase 3 data for its Trodelvy immunotherapy combined with Merck's Keytruda in frontline metastatic triple-negative breast cancer, marking a significant stride in its strategic pivot to expand beyond virology. The company also bolsters its pipeline through a new partnership with Repare Therapeutics.

Feb 3, 2026

Business

MicroStrategy's High-Stakes Bet: Bitcoin's Slide Tests the Limits of a Leveraged Strategy

As Bitcoin retreated from recent highs, MicroStrategy's massive holdings briefly slipped into unrealized loss territory, casting fresh doubt on the company's aggressive, debt-fueled crypto accumulation strategy and sending its shares tumbling.

Feb 3, 2026

Business

Dimon's Davos Clash with Crypto, Trump's $5B Lawsuit Spotlight JPMorgan's Tumultuous Week

JPMorgan Chase faces dual fronts of disruption as CEO Jamie Dimon's public critique of stablecoins at Davos highlights escalating tensions with the crypto sector, while a major lawsuit from former President Donald Trump alleges political bias, placing the banking giant's strategy and resilience under intense scrutiny.

Feb 3, 2026

Business

Beyond the Blue Chips: Three European Micro-Caps Poised for Growth in February 2026

As the Eurozone's patchy recovery creates divergent opportunities, we spotlight three small-cap stocks—from Dutch media to Swedish medtech and satcom—that combine financial resilience with high-growth potential for the discerning investor.

Feb 3, 2026

US

Clintons Agree to Testify in Epstein Probe After House Contempt Threat

Former President Bill Clinton and former Secretary of State Hillary Clinton have agreed to appear before the House Oversight Committee, averting a contempt vote after weeks of tense negotiations and political pressure surrounding the Jeffrey Epstein investigation.

Feb 3, 2026

Business

Steady Income in a Volatile Market: Three Midstream Energy Picks for 2026

Amidst energy sector turbulence, midstream giants Enbridge, Enterprise Products, and Energy Transfer offer investors high yields backed by fee-based, infrastructure-heavy business models.

Feb 3, 2026

Business

Knight-Swift Stock Surges 7% as Industry Veteran Returns to Helm Amid Market Headwinds

Shares of Knight-Swift Transportation Holdings jumped sharply Monday after the trucking giant appointed former executive Joe Vitiritto as president, signaling a strategic shift to navigate a softening freight market and recent earnings slump.

Feb 3, 2026

Business

Norwegian Cruise Line Holdings Soars on Record Demand for New Oceania Sonata

Shares of Norwegian Cruise Line Holdings surged over 7% Monday, fueled by unprecedented booking figures for its newly announced ship, the Oceania Sonata, signaling robust consumer appetite in the luxury cruise segment.

Feb 3, 2026

Business

Carnival Stock Surges 8% on Dividend Announcement and Sector Optimism

Shares of Carnival Corporation & plc (NYSE: CCL) jumped sharply Monday, buoyed by a new dividend payment and a wave of positive sentiment sweeping the cruise industry following strong results from a key competitor.

Feb 3, 2026

Business

Corning Shares Surge on Rare Earths Stockpile Project, Meta Deal Momentum

Corning Inc. (GLW) stock jumped nearly 7% Monday, fueled by investor optimism over its participation in a major federal rare earths initiative and a recent multi-billion dollar supply agreement with Meta Platforms.

Feb 3, 2026

World

House GOP Faces Crucial Test Vote to Avert Shutdown as Johnson Navigates Trump's Demands

Speaker Mike Johnson confronts a pivotal procedural vote Tuesday, needing near-unanimous Republican support to pass a stopgap funding bill and end a partial government shutdown, all while managing pressure from former President Trump and internal party divisions.

Feb 3, 2026

US

Gabbard Defends Role in FBI Election Center Search, Citing National Security Mandate

Director of National Intelligence Tulsi Gabbard has formally justified her presence at an FBI search of a Georgia election facility, asserting her actions were within her legal authority to protect election integrity from foreign threats.

Feb 3, 2026

Business

Flowco Bolsters Permian Presence with $200 Million Acquisition of Valiant Artificial Lift

Flowco (NYSE: FLOC) has struck a deal to acquire Valiant Artificial Lift Solutions for $200 million, a move that significantly expands its electric submersible pump (ESP) capabilities in the key Permian Basin and broadens its production optimization portfolio.

Feb 3, 2026